+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bacterial Conjunctivitis"

Bacterial Conjunctivitis Market Report 2025 - Product Thumbnail Image

Bacterial Conjunctivitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Bacterial Conjunctivitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial Conjunctivitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Conjunctivitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Conjunctivitis Treatment - Global Strategic Business Report

  • Report
  • March 2025
  • 379 Pages
  • Global
From
Conjunctivitis Treatment Market Report 2025 - Product Thumbnail Image

Conjunctivitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bacterial Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bacterial Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Conjunctivitis Therapeutics Market 2021-2025 - Product Thumbnail Image

Conjunctivitis Therapeutics Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
From
From
Allergic Conjunctivitis Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Allergic Conjunctivitis Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator

Bacterial conjunctivitis is an eye condition that results from infection by bacteria, leading to inflammation of the conjunctiva, the thin, transparent layer of tissue covering the white part of the eye and the inner surfaces of the eyelids. In the context of the optical market, bacterial conjunctivitis has a direct impact on eye care products and services. Treatment typically involves the use of antibiotic eye drops or ointments, which are prescribed by healthcare professionals, including optometrists and ophthalmologists. The optical market encompasses the manufacturing and distribution of these treatments, as well as over-the-counter products that provide relief from symptoms. Additionally, this market includes the broader scope of eye care, with providers offering diagnostic and prescription services to manage and resolve infections. The pharmaceutical sector plays a central role within the bacterial conjunctivitis market through the development and distribution of antibacterial agents suitable for ophthalmic use. As of the last knowledge update, companies engaged in either the development or supply of treatments for bacterial conjunctivitis include Pfizer Inc., Novartis AG, Allergan, Santen Pharmaceutical Co., Ltd., and Valeant Pharmaceuticals International, Inc. These companies, along with others in the field, are instrumental in addressing the demand for effective conjunctivitis management and treatment options. Show Less Read more